Novel therapies for prevention of left ventricular remodeling following myocardial infarction
Heart failure (HF) following myocardial infarction (MI) is the leading cause of mortality and morbidity worldwide. Existing medical and interventional therapies can only reduce the cardiomyocytes (CMs) lost during MI. They are unable to replenish the permanent loss of CMs and this contributes to pro...
| Main Authors: | , |
|---|---|
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/197141 |